Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

InFlectis BioScience

InFlectis BioScience?uq=iauh9QUh
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$6.74M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of small molecule drugs intended to maximize the commercial value of each of its products, improve patient care and generate significant financial returns to its shareholders. The company's small molecule drugs identify preclinical-stage development products that modulate key proteins involved in misfolded protein disorders areas through early proof-of-concept, enabling patients to develop a stronger cellular defense system.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 21 rue La Noue Bras de Fer
  • 44200 Nantes
  • France

+33 02 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore InFlectis BioScience’s full profile, request a free trial.

InFlectis BioScience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 01-Jun-2016 $6.74M 00.000 Completed Generating Revenue
2. Seed Round 13-Jan-2015 00.000 00.000 Completed Generating Revenue
1. Grant 01-Jan-2014 $409K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

InFlectis BioScience Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
CM-CIC Capital Innovation Venture Capital Minority 000 0000 000000 0
Remiges Ventures Venture Capital Minority 000 0000 000000 0
GO Capital (France) Venture Capital Minority 000 0000 000000 0
Participations Besançon Other Minority 000 0000 000000 0
French Research Ministry Government 000 0000 000000 0

InFlectis BioScience Executive Team (3)

Name Title Board
Seat
Contact
Info
Philippe Guedat Ph.D Co-Founder, Chief Executive Officer, Publication Director, Managing Director & President
Philippe Jaffré Chief Financial Officer
Pierre Miniou Ph.D Co-Founder & Chief Business Officer

InFlectis BioScience Board Members (1)

Name Representing Role Since Contact
Info
Jérôme Guéret GO Capital (France) Board Member 000 0000